ETBX-041

N/A

Report date: 2022/09/09 20:00:42

Base Information

Drug NameETBX-041
Drug Alias NameAd5 [E1-, E2b-]-E6 ∆/E7 ∆non-oncogenic HPV 16 E6/E7
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEtubics CorpSanford Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanford HealthEtubics Corp
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A